Akari Therapeutics Plc Quarterly Liabilities in USD from Q4 2014 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
Akari Therapeutics Plc quarterly Liabilities history and growth rate from Q4 2014 to Q2 2024.
  • Akari Therapeutics Plc Liabilities for the quarter ending June 30, 2024 was $24M, a 359% increase year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $24M +$18.8M +359% Jun 30, 2024 8-K 2024-09-06
Q4 2023 $20.8M +$5.13M +32.8% Dec 31, 2023 8-K 2024-09-06
Q2 2023 $5.23M +$2.19M +71.8% Jun 30, 2023 6-K 2023-09-29
Q4 2022 $15.6M +$9.53M +156% Dec 31, 2022 8-K 2024-09-06
Q2 2022 $3.05M -$196K -6.06% Jun 30, 2022 6-K 2022-09-27
Q4 2021 $6.09M +$873K +16.7% Dec 31, 2021 20-F 2023-05-01
Q2 2021 $3.24M -$5.25M -61.8% Jun 30, 2021 6-K 2021-09-22
Q4 2020 $5.22M -$1.25M -19.3% Dec 31, 2020 20-F 2022-05-16
Q3 2020 $6.75M +$1.38M +25.7% Sep 30, 2020 20-F 2021-04-21
Q2 2020 $8.49M +$4.34M +105% Jun 30, 2020 20-F 2021-04-21
Q1 2020 $6.41M +$3.02M +89.2% Mar 31, 2020 20-F 2021-04-21
Q4 2019 $6.47M +$1.55M +31.6% Dec 31, 2019 20-F 2021-04-21
Q3 2019 $5.37M Sep 30, 2019 20-F 2021-04-21
Q2 2019 $4.15M -$4.34M -51.1% Jun 30, 2019 20-F 2021-04-21
Q1 2019 $3.39M Mar 31, 2019 20-F 2021-04-21
Q4 2018 $4.92M -$6.98M -58.7% Dec 31, 2018 20-F 2020-03-31
Q2 2018 $8.49M -$709K -7.7% Jun 30, 2018 6-K 2018-09-27
Q4 2017 $11.9M +$125K +1.06% Dec 31, 2017 20-F 2019-04-23
Q2 2017 $9.2M -$7.85M -46% Jun 30, 2017 6-K 2017-08-10
Q4 2016 $11.8M -$9.4M -44.4% Dec 31, 2016 20-F 2018-07-18
Q2 2016 $17M Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 $16.6M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $21.2M +$20M +1708% Dec 31, 2015 6-K/A 2017-04-14
Q3 2015 $37.8M Sep 30, 2015 10-Q 2015-11-23
Q4 2014 $1.17M Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.